Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-70.78M
↓ 91% below average
Average (9y)
$-37.01M
Historical baseline
Range
High:$90.85M
Low:$-123.48M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $-70.78M | +32.3% |
| 2024 | $-104.51M | +15.4% |
| 2023 | $-123.48M | -3.6% |
| 2022 | $-119.22M | -14.4% |
| 2021 | $-104.25M | -174.4% |
| 2020 | $-37.99M | -195.0% |
| 2019 | $40.00M | -56.0% |
| 2018 | $90.85M | +239.6% |
| 2017 | $26.75M | -17.7% |
| 2016 | $32.50M | - |